Prevalence of cardiovascular symptoms in post-acute COVID-19 syndrome: a meta-analysis - BMC Medicine
In a review of 37 studies, encompassing 2,965,467 patients, 15% of Covid survivors suffered from cardiovascular sequelae.
COVID-19 raises the stakes for heart attacks, strokes, and even death long after infection, new study finds
“COVID-19 raises the stakes for heart attacks, strokes, and even death long after infection, new study finds”
COVID-19 raises the stakes for heart attacks, strokes, and even death long after infection, new study finds
COVID-19 raises the stakes for heart attacks, strokes, and even death long after infection, new study finds
“COVID-19 raises the stakes for heart attacks, strokes, and even death long after infection, new study finds”
COVID-19 raises the stakes for heart attacks, strokes, and even death long after infection, new study finds
The Cardiac pathophysiology of Covid-19
“Findings emphasize that Covid-19’s myocardial pathology predominantly arises from fibrin thrombi within the coronary MICROVASCULAR network, especially in the abluminal spaces.
➡️This pathological process leads to myocardial fibre injury, necrosis, and ischemic changes( = fibrosis), contributing to both the acute symptoms and long-term sequelae (Long Covid).”
Remodeling of intracellular architecture during SARS-CoV-2 infection of human endothelium
Covid, and even asymptomatic covid is an endothelial disease.
Polish study Study on endothelial cells shows SARS-CoV-2 disrupts cell elasticity, causing vascular damage even without full replication.
“Clinical data indicate that COVID-19 causes cardiovascular complications, regardless of the severity of the disease. In this work, we have shown that SARS-CoV-2 infection causes vascular dysfunction due to the modification of endothelial cell elasticity.”
COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type | Arteriosclerosis, Thrombosis, and Vascular Biology
“COVID-19 at all levels of severity was associated with significantly higher risk of MI, stroke, or all-cause mortality over 1003 days of follow-up."